[
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc. (GILD) and Kite to Present Breakthrough Cancer Therapy Data at 2025 ASCO and EHA",
    "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) plans to present over 20 research abstracts—spanning both Gilead and its cell therapy unit Kite—at two major medical conferences: the 2025 ASCO Annual Meeting (May 30–June 3) and the 2025 EHA Congress (June 12–15). The presentations will cover a range of cancers, including breast cancer, solid tumors, and various blood cancers. […]",
    "url": "https://finnhub.io/api/news?id=ce6b7320e91050def8af680602170e6a6b256295d0c8c152e66060945728e25b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747596417,
      "headline": "Gilead Sciences, Inc. (GILD) and Kite to Present Breakthrough Cancer Therapy Data at 2025 ASCO and EHA",
      "id": 134577376,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) plans to present over 20 research abstracts—spanning both Gilead and its cell therapy unit Kite—at two major medical conferences: the 2025 ASCO Annual Meeting (May 30–June 3) and the 2025 EHA Congress (June 12–15). The presentations will cover a range of cancers, including breast cancer, solid tumors, and various blood cancers. […]",
      "url": "https://finnhub.io/api/news?id=ce6b7320e91050def8af680602170e6a6b256295d0c8c152e66060945728e25b"
    }
  }
]